Nearly 90,000 bottles of children's ibuprofen voluntarily recalled
Key Points:
- Nearly 90,000 bottles of children's ibuprofen are being voluntarily recalled due to reports of a gel-like mass and black particles found in the medication.
- The recall affects four-ounce (120 ml) bottles of Children's Ibuprofen Oral Suspension with lot codes 7261973A and 7261974A, expiring on 01/31/2027, manufactured in India for Taro Pharmaceuticals U.S.A., Inc.
- The FDA has classified the recall as Class II, indicating the product may cause temporary or medically reversible adverse health effects, with serious consequences being unlikely.
- Taro Pharmaceuticals, a subsidiary of Sun Pharma, is working with its manufacturing partner Strides to investigate the issue and ensure regulatory compliance.